Standout Papers

2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN) 2024 202630
  1. 2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN) (2024)
    Danuta M. Skowronski, Suzana Sabaiduc et al. Eurosurveillance

Citation Impact

1 by Nobel laureates 4 from Science/Nature 54 standout
Sub-graph 1 of 24

Citing Papers

Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
2024 Standout
Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe
2023 Standout
2 intermediate papers

Works of Romy Olsha being referenced

Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV)
2019
Vaccine Effectiveness Against Laboratory-Confirmed Influenza Hospitalizations Among Elderly Adults During the 2010-2011 Season
2013

Author Peers

Author Epidemiology Infectious Diseases MS PHEOH Last Decade Papers Cites
Romy Olsha 393 273 56 101 26 541
Björn Schünemann 1 10 114
David Cast 13 206
Antonio Tineo 142 395 46 564
Hadi Akbarzadeh 63 1.7k
Maria‐Katharina Ganten 12 3 1 11 349

All Works

Loading papers...

Rankless by CCL
2026